Correlation Between Protara Therapeutics and Icosavax
Can any of the company-specific risk be diversified away by investing in both Protara Therapeutics and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protara Therapeutics and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protara Therapeutics and Icosavax, you can compare the effects of market volatilities on Protara Therapeutics and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protara Therapeutics with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protara Therapeutics and Icosavax.
Diversification Opportunities for Protara Therapeutics and Icosavax
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Protara and Icosavax is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Protara Therapeutics and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Protara Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protara Therapeutics are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Protara Therapeutics i.e., Protara Therapeutics and Icosavax go up and down completely randomly.
Pair Corralation between Protara Therapeutics and Icosavax
If you would invest 189.00 in Protara Therapeutics on September 21, 2024 and sell it today you would earn a total of 350.00 from holding Protara Therapeutics or generate 185.19% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Protara Therapeutics vs. Icosavax
Performance |
Timeline |
Protara Therapeutics |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protara Therapeutics and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Protara Therapeutics and Icosavax
The main advantage of trading using opposite Protara Therapeutics and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protara Therapeutics position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Protara Therapeutics vs. Vaccinex | Protara Therapeutics vs. Monopar Therapeutics | Protara Therapeutics vs. Surrozen | Protara Therapeutics vs. Ikena Oncology |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |